Table 2.
The distribution of patients over the quartiles analyzed, showing the overlap of patients between the cumulative dose quartiles and cumulative time quartiles.
| Cumulative dose of sc IFN beta-1a | Cumulative time on sc IFN beta-1a |
Total, n | |||
|---|---|---|---|---|---|
| 1st quartile [MIN], n | 2nd quartile, n | 3rd quartile, n | 4th quartile [MAX], n | ||
| 1st quartile [MIN], n | 69 | 26 | 1 | 0 | 96 |
| 2nd quartile, n | 18 | 27 | 25 | 25 | 95 |
| 3rd quartile, n | 9 | 32 | 31 | 24 | 96 |
| 4th quartile [MAX], n | 0 | 10 | 39 | 46 | 95 |
| Total, n | 96 | 95 | 96 | 95 | 382 |
IFN, interferon; MAX, maximum (highest quartile); MIN, minimum (lowest quartile); sc, subcutaneous.